Paul Grint
Executive Chairman & Interim CEO at Codagenix
Find your path to Paul
2 people in our graph share verified history with Paul — schools, employers, funds. One of them is your warm intro.
Glenn RockmanunlockedPaul: together at Codagenix
Paul: together at Codagenix
About
Grint has led several biopharmaceutical companies, serving as CEO of AmpliPhi Biosciences and as President and CEO of Regulus Therapeutics. He also chairs CRISPR QC, is an entrepreneur in residence at the University of California San Diego, and has served on the boards of Persephone Biosciences, Inhibikase Therapeutics, and Synedgen.
Executive Chairman & Interim CEO at Codagenix
Intro paths
→
In turn, Paul can intro founders to Codagenix's investors below.
Codagenix's investors · 6
Co-founders at Codagenix
JR
John Robert ColemanExecutive Officer, Director
SM
Steffen MuellerCo-Founder, President & Chief Scientific Officer
Frequently asked questions
- Who is Paul Grint?
- Grint has led several biopharmaceutical companies, serving as CEO of AmpliPhi Biosciences and as President and CEO of Regulus Therapeutics. He also chairs CRISPR QC, is an entrepreneur in residence at the University of California San Diego, and has served on the boards of Persephone Biosciences, Inhibikase Therapeutics, and Synedgen.
- Where does Paul Grint work?
- Paul Grint is Executive Chairman & Interim CEO at Codagenix.